The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | C | Cardiovascular system | |
2 | C03 | Diuretics | |
3 | C03B | Low-ceiling diuretics, excl. thiazides | |
4 | C03BA | Sulfonamides, plain |
Code | Title | |
---|---|---|
C03BA02 | Quinethazone | |
C03BA03 | Clopamide | |
C03BA04 | Chlorthalidone | |
C03BA05 | Mefruside | |
C03BA07 | Clofenamide | |
C03BA08 | Metolazone | |
C03BA09 | Meticrane | |
C03BA10 | Xipamide | |
C03BA11 | Indapamide | |
C03BA12 | Clorexolone | |
C03BA13 | Fenquizone | |
C03BA82 | Clorexolone, comb. with psycholeptics |
Active Ingredient | Description | |
---|---|---|
Chlortalidone |
Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action. |
|
Clopamide |
|
|
Indapamide |
Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action. |
|
Mefruside |
|
|
Metolazone |
Metolazone is a diuretic antihypertensive drug for the treatment of edema. Metolazone is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption. |
|
Xipamide |
Xipamide is an anti-hypertensive diuretic which can be characterised pharmacologically neither as a thiazide nor as a specific loop diuretic. Although structurally similar to chlorthalidone, it has a markedly different pharmacological profile with its main diuretic effect exerted at the distal section of the nephron. |
Title | Information Source | Document Type | |
---|---|---|---|
DIUREXAN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
FRUMERON Coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
HYGROTON Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
NATRILIX Prolonged-release tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ZAROXOLYN Tablet | Health Products and Food Branch (CA) | MPI, EU: SmPC |